Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D001960:Bromazepam / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000032:analysis; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000032:analysis; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D014151:Anti-Anxiety Agents; D015102:3,4-Dihydroxyphenylacetic Acid; D012701:Serotonin; D008734:Methoxyhydroxyphenylglycol; D003975:Diazepam; D004298:Dopamine; D001960:Bromazepam; D009638:Norepinephrine; D006719:Homovanillic Acid